EUVIMEDEUVIMED entdecken
Crossref

Oxaloacetate Restores HIF ‐1α‐Mediated Mitochondrial Homeostasis to Counter Tubulointerstitial Injury in Diabetic Kidney Disease

Yao Zhang, Jia-Ling Ji, Dan-Dan Yao, Yan Zhou, Cong-Cong Liu, Zhen-Lin Tang, Jia-Le Xue, Bi-Cheng Liu, Zuo-Lin Li iD, Rui-Xia Ma

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Yao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Diabetic Nephropathies, Mitochondria, Oxaloacetic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, ZhiShan Scholar Program of Southeast University, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Renal tubular injury, one of the most critical events in diabetic kidney disease (DKD), plays a pivotal role in the progression of the disease. Metabolic reprogramming of renal tubular cells emerges as a prominent pathological feature, yet its underlying molecular mechanisms remain incompletely understood.

Methods

We established a streptozotocin‐induced mouse model of diabetes. Metabolomic analysis was then used to characterise DKD‐specific metabolic alterations. To test the functional consequence of a metabolic intervention, DKD mice received intraperitoneal injections of oxaloacetate (OAA). Furthermore, molecular docking and cellular thermal shift assays were used to elucidate the molecular mechanisms underlying OAA's effects on renal tubular injury, which were further validated in HK‐2 cells exposed to high glucose. Finally, a specific pharmacological inhibitor was applied to study the relevant signalling pathway.

Results

Metabolomic profiling identified a marked decrease in OAA, a key tricarboxylic acid (TCA) cycle intermediate, in injured renal tubular cells. OAA supplementation significantly attenuated tubulointerstitial injury, as evidenced by reduced tubular cell damage, fibrosis, and macrophage infiltration. Moreover, restored mitochondrial homeostasis was observed in DKD mice after OAA treatment. Mechanistically, we found that OAA inhibited prolyl hydroxylase domain 2 (PHD2), an essential regulator of hypoxia‐inducible factor‐1α (HIF‐1α), thereby stabilising mitochondrial homeostasis. Furthermore, pharmacological inhibition of HIF‐1α abolished the protective effects of OAA, confirming the involvement of the PHD2/HIF‐1α axis.

Conclusions

OAA ameliorates renal tubulointerstitial injury in DKD by restoring mitochondrial homeostasis through the PHD2/HIF‐1α axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitDiabetic NephropathiesMitochondriaOxaloacetic AcidDiabetes Mellitus, ExperimentalKidney TubulesAnimalsMiceHomeostasisMaleHumansMice, Inbred C57BLSignal TransductionCell LineHypoxia-Inducible Factor-Proline Dioxygenases

Stichwörter der Autor:innen

HIF‐1αdiabetic kidney diseasemitochondrial homeostasisoxaloacetatetubulointerstitial injury

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitOxaloacetic AcidHif1a protein, mouseHypoxia-Inducible Factor-Proline Dioxygenases

Autor:innen und Institutionen

  • Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Department of Pediatrics, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Nephrology, Chengyang District People's Hospital, Qingdao, Shandong, China.
  • Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
  • Department of Internal Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.

ORCID-Profile: Zuo-Lin Li

Förderung

  • Natural Science Foundation of Jiangsu Province
  • ZhiShan Scholar Program of Southeast University
  • Natural Science Foundation of Shandong Province
  • Taishan Scholar Program of Shandong Province
  • Qingdao Medical and Health Research Program Project
  • Qingdao Key Health Discipline Development Fund
  • Qingdao Key Clinical Specialty Elite Discipline
  • Science and Technology Development Foundation of Nanjing Medical University

Zitieren

APA

Zhang, Y., Ji, J. L., Yao, D. D., Zhou, Y., Liu, C. C., Tang, Z. L., Xue, J. L., Liu, B. C., Li, Z. L., & Ma, R. X. (2026). Oxaloacetate Restores HIF ‐1α‐Mediated Mitochondrial Homeostasis to Counter Tubulointerstitial Injury in Diabetic Kidney Disease. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70612

Vancouver

Zhang Y, Ji JL, Yao DD, Zhou Y, Liu CC, Tang ZL, et al. Oxaloacetate Restores HIF ‐1α‐Mediated Mitochondrial Homeostasis to Counter Tubulointerstitial Injury in Diabetic Kidney Disease. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70612

BibTeX
@article{Zhang2026,
  author = {Zhang, Yao and Ji, Jia-Ling and Yao, Dan-Dan and Zhou, Yan and Liu, Cong-Cong and Tang, Zhen-Lin and Xue, Jia-Le and Liu, Bi-Cheng and Li, Zuo-Lin and Ma, Rui-Xia},
  title = {Oxaloacetate Restores HIF ‐1α‐Mediated Mitochondrial Homeostasis to Counter Tubulointerstitial Injury in Diabetic Kidney Disease},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70612}
}
Kostenlos starten →